154 related articles for article (PubMed ID: 11839636)
1. Calmodulin inhibitor W-7 unmasks a novel electrocardiographic parameter that predicts initiation of torsade de pointes.
Gbadebo TD; Trimble RW; Khoo MS; Temple J; Roden DM; Anderson ME
Circulation; 2002 Feb; 105(6):770-4. PubMed ID: 11839636
[TBL] [Abstract][Full Text] [Related]
2. Systemic administration of calmodulin antagonist W-7 or protein kinase A inhibitor H-8 prevents torsade de pointes in rabbits.
Mazur A; Roden DM; Anderson ME
Circulation; 1999 Dec; 100(24):2437-42. PubMed ID: 10595957
[TBL] [Abstract][Full Text] [Related]
3. K201, a multi-channel blocker, inhibits clofilium-induced torsades de pointes and attenuates an increase in repolarization.
Hasumi H; Matsuda R; Shimamoto K; Hata Y; Kaneko N
Eur J Pharmacol; 2007 Jan; 555(1):54-60. PubMed ID: 17112502
[TBL] [Abstract][Full Text] [Related]
4. [Calmodulin antagonist inhibits torsade de pointes induced by d-sotalol in an isolated rabbit heart model].
Pu J; Zhang CT; Bai R; Liu N; Li Y; Wang L
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Apr; 33(4):364-8. PubMed ID: 15932674
[TBL] [Abstract][Full Text] [Related]
5. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits.
Wang WQ; Robertson C; Dhalla AK; Belardinelli L
J Pharmacol Exp Ther; 2008 Jun; 325(3):875-81. PubMed ID: 18322148
[TBL] [Abstract][Full Text] [Related]
6. The electromechanical window is no better than QT prolongation to assess risk of Torsade de Pointes in the complete atrioventricular block model in dogs.
Stams TR; Bourgonje VJ; Beekman HD; Schoenmakers M; van der Nagel R; Oosterhoff P; van Opstal JM; Vos MA
Br J Pharmacol; 2014 Feb; 171(3):714-22. PubMed ID: 24490860
[TBL] [Abstract][Full Text] [Related]
7. Beat-by-beat QT interval variability, but not QT prolongation per se, predicts drug-induced torsades de pointes in the anaesthetised methoxamine-sensitized rabbit.
Jacobson I; Carlsson L; Duker G
J Pharmacol Toxicol Methods; 2011; 63(1):40-6. PubMed ID: 20451633
[TBL] [Abstract][Full Text] [Related]
8. AV-block and conduction slowing prevail over TdP arrhythmias in the methoxamine-sensitized pro-arrhythmic rabbit model.
Varkevisser R; Vos MA; Beekman JD; Tieland RG; Van Der Heyden MA
J Cardiovasc Electrophysiol; 2015 Jan; 26(1):82-9. PubMed ID: 25154623
[TBL] [Abstract][Full Text] [Related]
9. Effects of adenosine A1-receptor activation on torsade de pointes in rabbits.
Tan HL; Hou CJ; Sung RJ
Cardiovasc Drugs Ther; 1999 Sep; 13(5):441-7. PubMed ID: 10547225
[TBL] [Abstract][Full Text] [Related]
10. Antiarrhythmic effects of potassium channel openers in rhythm abnormalities related to delayed repolarization.
Carlsson L; Abrahamsson C; Drews L; Duker G
Circulation; 1992 Apr; 85(4):1491-500. PubMed ID: 1555289
[TBL] [Abstract][Full Text] [Related]
11. Noninvasive cardiac activation imaging of ventricular arrhythmias during drug-induced QT prolongation in the rabbit heart.
Han C; Pogwizd SM; Killingsworth CR; Zhou Z; He B
Heart Rhythm; 2013 Oct; 10(10):1509-15. PubMed ID: 23773986
[TBL] [Abstract][Full Text] [Related]
12. Combined pharmacological block of I(Kr) and I(Ks) increases short-term QT interval variability and provokes torsades de pointes.
Lengyel C; Varró A; Tábori K; Papp JG; Baczkó I
Br J Pharmacol; 2007 Aug; 151(7):941-51. PubMed ID: 17533421
[TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model.
Zabel M; Hohnloser SH; Behrens S; Li YG; Woosley RL; Franz MR
J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1148-58. PubMed ID: 9363818
[TBL] [Abstract][Full Text] [Related]
14. KN-93, A CaMKII inhibitor, suppresses ventricular arrhythmia induced by LQT2 without decreasing TDR.
Wang WL; Zhang SS; Deng J; Zhao JY; Zhao CQ; Lin L; Zhang CT; Lv JG
J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):636-639. PubMed ID: 24142712
[TBL] [Abstract][Full Text] [Related]
15. Giant T-U waves precede torsades de pointes in long QT syndrome: a systematic electrocardiographic analysis in patients with acquired and congenital QT prolongation.
Kirchhof P; Franz MR; Bardai A; Wilde AM
J Am Coll Cardiol; 2009 Jul; 54(2):143-9. PubMed ID: 19573731
[TBL] [Abstract][Full Text] [Related]
16. A new biomarker--index of cardiac electrophysiological balance (iCEB)--plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs).
Lu HR; Yan GX; Gallacher DJ
J Pharmacol Toxicol Methods; 2013; 68(2):250-259. PubMed ID: 23337247
[TBL] [Abstract][Full Text] [Related]
17. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
Shimizu W; Antzelevitch C
Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
[TBL] [Abstract][Full Text] [Related]
18. Electrocardiographic Predictors of Torsadogenic Risk During Dofetilide or Sotalol Initiation: Utility of a Novel T Wave Analysis Program.
Sugrue A; Kremen V; Qiang B; Sheldon SH; DeSimone CV; Sapir Y; Striemer BL; Brady P; Asirvatham SJ; Ackerman MJ; Friedman P; Noseworthy PA
Cardiovasc Drugs Ther; 2015; 29(5):433-41. PubMed ID: 26411977
[TBL] [Abstract][Full Text] [Related]
19. Nonselective I(Kr)-blockers do not induce torsades de pointes in the anesthetized rabbit during alpha1-adrenoceptor stimulation.
Lu HR; Remeysen P; De Clerck F
J Cardiovasc Pharmacol; 2000 Dec; 36(6):728-36. PubMed ID: 11117372
[TBL] [Abstract][Full Text] [Related]
20. Verapamil prevents torsade de pointes by reduction of transmural dispersion of repolarization and suppression of early afterdepolarizations in an intact heart model of LQT3.
Milberg P; Reinsch N; Osada N; Wasmer K; Mönnig G; Stypmann J; Breithardt G; Haverkamp W; Eckardt L
Basic Res Cardiol; 2005 Jul; 100(4):365-71. PubMed ID: 15944809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
